The earnings call highlighted strong growth in key segments like USA Orthopedics and Spinal Fixation, successful product launches, and improved financial metrics including gross margin and cash flow. However, challenges such as pricing impacts and international sales decline were noted. Overall, the positive aspects outweighed the negative ones, suggesting a strong performance and optimistic outlook.

Company Guidance -

Q3 2025

During the Orthofix Second Quarter 2025 Earnings Call, several key metrics and guidance details were shared. Orthofix reported pro forma net sales of $200.7 million, reflecting a year-over-year constant currency growth of 4%. The USA Spinal Fixation net sales grew by 5.4%, accompanied by a 7% increase in procedure volume. The company also noted a significant 66% growth in 7D FLASH navigation system placements in the first half of 2025 compared to the previous year. The U.S. Orthopedics segment grew by 28%, driven by the launch of the TrueLok Elevate system. Adjusted EBITDA margin expanded by approximately 190 basis points to 10.3% of net sales, with free cash flow generation amounting to $4.5 million. For the full year 2025, Orthofix maintained guidance for pro forma net sales between $808 million and $816 million and adjusted EBITDA of $82 million to $86 million, with expectations of continued positive free cash flow.

Positive Net Sales Growth

Pro forma net sales reached $200.7 million, representing a year-over-year constant currency growth of 4%.

Strong Performance in USA Spinal Fixation

Net sales grew 5.4% with a 7% increase in procedure volume, consistent with company expectations.

USA Orthopedics Growth

U.S. Orthopedics grew 28%, driven by strong execution and product launches, marking the fourth consecutive quarter of double-digit growth.

7D FLASH Navigation System Success

U.S. unit placements grew by 66% in H1 2025 compared to the prior year, representing a total revenue commitment of $12 million over 3-4 years.

Launch of VIRATA Spinal Fixation System

Received FDA clearance and initiated limited market release, expected to contribute to growth in the coming years.

Record Orthopedics Product Launch

TrueLok Elevate Transverse Bone Transport System in full market release globally, expanding presence in diabetic wound market.

Improved Adjusted Gross Margin

Pro forma non-GAAP adjusted gross margin reached 72.7%, a 140 basis point increase from the previous year.

Positive Free Cash Flow

Generated positive free cash flow of $4.5 million in Q2, with a total cash balance of $68.7 million.

Orthofix (OFIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OFIX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	-0.33 / -	-0.71	―	―	―
Jun 30, 2025	2025 (Q2)	-0.49 / -0.36	-0.88	59.09% (+0.52)	―	―
May 06, 2025	2025 (Q1)	-0.55 / -1.35	-0.95	-42.11% (-0.40)
Feb 25, 2025	2024 (Q4)	-0.29 / -0.75	-0.59	-27.12% (-0.16)
Nov 07, 2024	2024 (Q3)	-0.34 / -0.71	0.07	-1114.29% (-0.78)
Aug 06, 2024	2024 (Q2)	-0.36 / -0.88	0.02	-4500.00% (-0.90)
May 07, 2024	2024 (Q1)	-0.51 / -0.95	-0.1	-850.00% (-0.85)
Mar 05, 2024	2023 (Q4)	0.06 / -0.59	0.19	-410.53% (-0.78)
Nov 08, 2023	2023 (Q3)	-0.21 / 0.07	0.13	-46.15% (-0.06)	―
Aug 08, 2023	2023 (Q2)	-0.60 / 0.02	0.08	-75.00% (-0.06)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OFIX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jun 30, 2025	$11.09	$11.15	+0.54%
May 06, 2025	$13.54	$12.06	-10.93%
Feb 25, 2025	$18.15	$17.51	-3.53%
Nov 07, 2024	$18.40	$18.22	-0.98%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orthofix International (OFIX) report earnings?

Orthofix International (OFIX) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).

What is Orthofix International (OFIX) earnings time?

Orthofix International (OFIX) earnings time is at Nov 06, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OFIX EPS forecast?

OFIX EPS forecast for the fiscal quarter 2025 (Q3) is -0.33.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing